| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3915 |
| Trial ID | NCT06469190 |
| Disease | Nephropathy |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | KN5501|CD19 CAR-NK cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | An Exploratory Clinical Study of the Safety and Efficacy of Anti-CD19 Chimeric Antigen Receptor NK Cell Injections (KN5501) in the Treatment of Relapsed/Refractory Immune Nephropathy |
| Year | 2024 |
| Country | China |
| Company sponsor | Changhai Hospital |
| Other ID(s) | CHEC2024-188 |
| Cohort 1 | |||||||||
|
|||||||||